The complex in Broadmeadows, in Melbourne’s north, accounts for almost half of CSL’s current $2bn-plus Australian capital investment program. The factory will separate the various components of human ...

CSL’s major new factory will fuel a nine-fold increase in its plasma processing capacity in Australia. Mr Perreault said the factory would turbocharge production of CSL’s life-saving therapies, ...

Mr Perreault said the factory would turbocharge production of CSL’s life-saving therapies, processing up to 9.2 million plasma equivalent litres a year – a nine-fold increase on CSL’s current capacity ...

Don't miss out on the headlines from Business. Followed categories will be added to My News. Mr Perreault said the factory would turbocharge production of CSL’s life-saving therapies, processing up to ...